International
-
Bristol part of new £4 million FDA study to advance understanding of severe coronavirus infection
5 October 2020
Bristol is part of a major new international project to improve our understanding of severe coronavirus infection in humans. The study, funded by the US Food and Drug Administration (FDA), will analyse samples from humans and animals to create profiles of various coronaviruses, including SARS-CoV-2, which causes COVID-19. The results will help inform the development of new treatments and vaccines to tackle coronavirus infections.
-
Charity launches scar-free healing research campaign
19 July 2016
A major medical research campaign to achieve scar-free healing within a generation was launched in London today.
-
Rapid point-of-care testing during and after COVID-19 – how widely should it be used?
17 November 2020
Even before the COVID-19 pandemic, the point-of-care testing industry was investing millions of pounds to develop rapid tests to tell us the cause of respiratory infections. The pandemic has accelerated this process. In an editorial published in the British Journal of General Practice today [17 November], researchers from the University of Bristol’s Centre for Academic Primary Care ask if we know enough about these tests to merit their widespread use in primary care.
-
Mud-slurping chinless ancestors had all the moves
1 October 2020
A team of researchers, led by the University of Bristol, has revealed our most ancient ancestors were ecologically diverse, despite lacking jaws and paired fins.
-
Mobile species are ‘glue’ which connect different habitats together, study finds
21 August 2024
A groundbreaking study conducted across 30 field sites in the southwest UK has revealed the importance of incorporating varied habitats into the landscape at large.
-
Overall COVID-19 intensive care mortality has fallen by a third
15 July 2020
A systematic review and meta-analysis of published studies from three continents shows overall mortality of COVID-19 patients in intensive care units (ICUs) has fallen from almost 60 per cent at the end of March to 42 per cent at the end of May — a relative decrease of one third since the start of the pandemic.
-
Robot jaws shows medicated chewing gum could be the future
14 July 2020
Medicated chewing gum has been recognised as a new advanced drug delivery method but currently there is no gold standard for testing drug release from chewing gum in vitro. New research has shown a chewing robot with built-in humanoid jaws could provide opportunities for pharmaceutical companies to develop medicated chewing gum.
-
Report reveals young people felt less anxious and more connected to school in lockdown
24 August 2020
Younger teenagers in the South West of England felt less anxious and more connected to school when they were away from it during the COVID-19 global pandemic public lockdown, a first-of-its-kind study has found.
-
New study sheds light on the debate surrounding two types of shoulder replacement surgery for osteoarthritis
1 May 2024
A new study has provided valuable insights into the ongoing debate surrounding two types of shoulder replacement surgery: reverse total shoulder replacement and anatomical total shoulder replacement as a treatment for patients with osteoarthritis.
-
Singing is no more risky than talking finds new COVID-19 study
20 August 2020
The performing arts has been badly affected during the coronavirus pandemic with live musical performances cancelled for many months because singing was identified as a potential "higher risk" activity. New collaborative research has shown that singing does not produce very substantially more respiratory particles than when speaking at a similar volume. The findings, published on the pre-print server ChemRxiv, are crucial in providing COVID-19 guidance for live musical performances and the safe distancing of performers and audience.
View the for public events and lectures run by the University.